MCHP Microchip Technology
Idle fabs make the recovery cheap, but the price already assumes a full return to mid-cycle margins.
The story
Microchip is a sticky, broad-catalog MCU and analog franchise with long design-in lifecycles and high switching costs, now climbing out of a severe inventory correction that cut revenue nearly in half. TTM revenue of 5.12B and a 15.3% operating margin confirm the recovery has started, and the fabs built for an 8B+ revenue base are badly underused, so volume can return with little new capital. It is a mature cyclical franchise, not a growth story, with 5.3B of net debt adding leverage to the cycle.
Growth, beta, horizon and failure risk stay where they were, because the recovery is playing out as expected (TTM revenue up about 9% over the last fiscal year, margin up from 10% to 15%). I raised sales-to-capital from 1.1 to 1.5 (a material move): capex of 0.09B against 0.67B of D&A shows large idle capacity, so the rebound back toward 7-8B needs little reinvestment. I nudged the target margin to 32% to sit inside the 33-37% mid-cycle GAAP range seen before the bust, still below peak.
Value drivers
| Revenue growth (Y1) | 18.0% |
| Terminal growth | 3.0% |
| Forecast horizon | 8y |
| Target operating margin | 32.0% |
| Years to target margin | 5 |
| Sales-to-capital | 1.50 |
| Beta | 1.20 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 10.2% |
| Terminal WACC | 9.4% |
Valuation bridge
| PV of explicit FCFF | 7.86B |
| PV of terminal value | 15.37B |
| Equity value | 17.61B |
| ÷ shares → per share | $32.43 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 6.04B | 18.0% | 18.7% | 948.57M | 614.68M | 333.89M | 303.05M |
| 2 | 7.00B | 15.9% | 22.0% | 1.30B | 638.97M | 656.39M | 540.72M |
| 3 | 7.96B | 13.7% | 25.3% | 1.70B | 640.25M | 1.06B | 789.60M |
| 4 | 8.88B | 11.6% | 28.7% | 2.14B | 614.30M | 1.53B | 1.04B |
| 5 | 9.72B | 9.4% | 32.0% | 2.62B | 558.46M | 2.06B | 1.27B |
| 6 | 10.43B | 7.3% | 32.0% | 2.81B | 472.23M | 2.33B | 1.31B |
| 7 | 10.97B | 5.1% | 32.0% | 2.95B | 357.62M | 2.59B | 1.32B |
| 8 | 11.30B | 3.0% | 32.0% | 3.04B | 219.34M | 2.82B | 1.30B |
Key risks
- The cyclical recovery stalls or double-dips as industrial and auto demand stays weak
- Chinese mature-node MCU competitors take share and squeeze pricing
- 5.3B of net debt magnifies equity losses if margins stay stuck in the teens
Catalysts
- Distributor and customer inventory normalizes, so sell-in recovers to match end demand
- Fab utilization rises, driving steep gross-margin and operating-margin recovery